M&A Deal Summary |
|
|---|---|
| Date | 2013-01-22 |
| Target | Molecular Insight Pharmaceuticals Inc |
| Sector | Healthcare Services |
| Buyer(s) | Progenics Pharmaceuticals |
| Deal Type | Add-on Acquisition |
| Deal Value | 106M USD |
| Advisor(s) | Torreya Partners (Financial) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1986 |
| Sector | Life Science |
| Employees | 79 |
| Revenue | 16M USD (2018) |
Progenics Pharmaceuticals, Inc. is a pharmaceutical company provides medicines to treat disease, focusing on cancer and related conditions with a pipeline that includes product candidates in preclinical through late-stage development. Progenics Pharmaceuticals was founded in 1986 and is based in New York City, New York.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Massachusetts M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |